Research Topics
| P J HauptmanSummaryAffiliation: Saint Louis University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Clinical challenge of hyponatremia in heart failurePaul J Hauptman
Division of Cardiology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri 63110, USA
J Hosp Med 7:S6-10. 2012..Even modest degrees of hyponatremia are associated with a poorer prognosis. Treatment options include fluid restriction and the vaptan class ("aquaretics") in select patients...
Angiography of potential cardiac donorsP J Hauptman
Department of Medicine, St Louis University School of Medicine, Missouri, USA
J Am Coll Cardiol 37:1252-8. 2001....
The business concept of leader pricing as applied to heart failure disease managementPaul J Hauptman
School of Medicine and Public Health, Saint Louis University, St Louis, Missouri, USA
Dis Manag 7:226-34. 2004..The actual magnitude of this benefit and the degree to which it mitigates overall administration costs requires further study...
Integrating palliative care into heart failure carePaul J Hauptman
Division of Cardiology, Saint Louis University School of Medicine, St Louis, MO 63110, USA
Arch Intern Med 165:374-8. 2005..Failure to respond to the need for palliative care puts at risk the mandate to treat the patient with heart failure during the entire course of illness...
Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failurePaul J Hauptman
Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, St Louis, MO, USA
JAMA 296:1877-84. 2006....
It is time to stop ignoring malignancy in heart transplantation: a call to armsPaul J Hauptman
St Louis University Health Sciences Center, MO 63110, USA
J Heart Lung Transplant 24:1111-3. 2005..Recommendations on malignancy screening are provided as well as an outline of areas of ongoing uncertainty...
Comparison of two doses and dosing regimens of tolvaptan in congestive heart failurePaul J Hauptman
Saint Louis University Health Sciences Center, 3635 Vista Avenue, St Louis, MO 63110, USA
J Cardiovasc Pharmacol 46:609-14. 2005..Based on these findings, tolvaptan 30 mg was chosen as the comparator for placebo in a large phase 3 survival trial...
Quality of life in advanced heart failure: role of mitral regurgitationPaul J Hauptman
Division of Cardiology, Department of Medicine, Saint Louis University Health Sciences Center, St Louis, MO, USA
Am Heart J 151:213-8. 2006....
Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice carePaul J Hauptman
Division of Cardiology, Saint Louis University Hospital, 3635 Vista Avenue, St Louis, MO 63110, USA
Arch Intern Med 167:1990-7. 2007..However, little is known about hospice referral practices when patients are admitted because of acute decompensated heart failure...
Medication adherence in heart failurePaul J Hauptman
Division of Cardiology, Saint Louis University School of Medicine, St Louis, Missouri, USA
Heart Fail Rev 13:99-106. 2008....
Chronic inotropic therapy in end-stage heart failurePaul J Hauptman
Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, St Louis, MO, USA
Am Heart J 152:1096.e1-8. 2006..However, little is known about associated mortality and cost. Therefore, we sought to describe the impact of chronic infusions on resource use and survival...
Measurement of end points in heart failure trials: jousting at windmills?Paul J Hauptman
Division of Cardiology and Department of Medicine, Saint Louis University School of Medicine, Saint Louis, MO, USA
Mt Sinai J Med 71:298-304. 2004....
Physician attitudes toward end-stage heart failure: a national surveyPaul J Hauptman
Division of Cardiology, Saint Louis University School of Medicine, St Louis, MO, USA
Am J Med 121:127-35. 2008..However, there is a paucity of data published describing physician beliefs about heart failure management, especially in its advanced stages...
Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital databasePaul J Hauptman
Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, St Louis, MO 63110, USA
Am Heart J 155:978-985.e1. 2008..However, little is known about the variability in and contributors to costs associated with HF hospitalizations. We examined the distribution of costs associated with a HF diagnosis in a large contemporary hospital database...
Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failurePaul J Hauptman
Saint Louis University School of Medicine, St Louis, Missouri, USA
Clin Cardiol 25:247-9. 2002..We conclude that some patients with advanced heart failure can be offered oral beta-blocker therapy by bridging with a combination of intravenous inotrope and short-acting intravenous beta blocker...
The heart failure clinic: a consensus statement of the Heart Failure Society of AmericaPaul J Hauptman
Division of Cardiology, Saint Louis University School of Medicine, St Louis, Missouri 63110, USA
J Card Fail 14:801-15. 2008..Outpatient care accounts for a significant proportion of total heart failure (HF) expenditures. This observation, plus an expanding list of treatment options, has led to the development of the disease-specific HF clinic...
Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization proceduresPaul J Hauptman
Department of Medicine, Division of Cardiology, Saint Louis University School of Medicine, St Louis, MO 63110, USA
Circ Cardiovasc Qual Outcomes 3:204-11. 2010..Our objective was to evaluate use of beta-blockers (BB) among patients with heart failure undergoing a cardiac device procedure...
Implantable cardiac device procedures in older patients: use and in-hospital outcomesJason P Swindle
Center for Outcomes Research, Saint Louis University School of Medicine, St Louis, MO 63110, USA
Arch Intern Med 170:631-7. 2010..We sought to characterize age-specific practices and outcomes among patients with heart failure undergoing device implantation using a large nationally representative administrative database...
Rationale and design of CASPER: compliance and quality of life study comparing once-daily carvedilol CR and twice-daily carvedilol IR in patients with heart failurePaul J Hauptman
Division of Cardiology, Saint Louis University School of Medicine, St. Louis, Missouri, USA
Am J Cardiol 98:60L-66L. 2006..The background, methods, and statistical approaches used in this trial are reviewed in this article...
Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart FJames E Udelson
Division of Cardiology, Tufts Medical Center, Boston, Massachusetts 02111, USA
J Card Fail 15:385-93. 2009....
Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failureJason Swindle
Center for Outcomes Research, Saint Louis University School of Medicine, St Louis, MO 63110, USA
Am Heart J 156:322-8. 2008..Therefore, we evaluated the inhospital mortality and costs associated with patients with heart failure who received an implantable cardioverter defibrillator, cardiac resynchronization device, or device lead...
The natural history of renal function following orthotopic heart transplantZiyad Al Aly
Division of Nephrology, Saint Louis University, Saint Louis, MO 63110, USA
Clin Transplant 19:683-9. 2005..The natural history of kidney function following orthotopic heart transplant is not well defined and long-term follow up studies are scant...
Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national surveyDeryk L McDowell
Division of Cardiology, Saint Louis University School of Medicine, St Louis, MO, USA
J Heart Lung Transplant 28:847-50. 2009..A device was implanted in 44 recipients (38 with defibrillator alone), and 6 had an appropriate discharge during follow-up. There was an interest in establishing a registry to enable further study and analysis...
Digoxin use and digoxin toxicity in the post-DIG trial eraZainal Hussain
Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA
J Card Fail 12:343-6. 2006..Further analyses are required to delineate the reasons underlying these trends and the appropriateness of prescribing practices for both digoxin and its antidote...
Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversiesKrista L Lentine
Center for Outcomes Research, Saint Louis University School of Medicine, St Louis, MO 63104, USA
Am J Kidney Dis 55:152-67. 2010..Biomarkers, such as cardiac troponin, have prognostic value in end-stage renal disease, but require further study to determine clinical applications in directing more expensive and invasive cardiac evaluation...
Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patientsKrista L Lentine
St Louis University Center for Outcomes Research, Salus Center, 2nd Floor, 3545 Lafayette Avenue, St Louis, MO 63104, USA
Clin J Am Soc Nephrol 3:1115-24. 2008..Evaluation for ischemic heart disease (IHD) is a nonstandardized practice before kidney transplantation. We retrospectively studied pretransplant cardiac evaluation (CE) practices in a national sample of renal allograft recipients...
Palliation in heart failure: when less and more are morePaul J Hauptman
Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA
Am J Hosp Palliat Care 23:150-2. 2006
Mode of death from congestive heart failure: implications for clinical managementMary Clare Derfler
Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, MO 63110, USA
Am J Geriatr Cardiol 13:299-304; quiz 305-6. 2004..The numbers of these patients is likely to increase in an era of implantable cardioverter-defibrillators. Intervention studies designed to evaluate and improve strategies that emphasize symptom control should target this group...
Progression of coronary artery disease in non-ischemic dilated cardiomyopathyOlaf Hedrich
Department of Medicine, School of Medicine, Saint Louis University, Missouri, USA
Coron Artery Dis 15:291-7. 2004..Risk factor modification strategies should be applied to the non-ischemic DCM cohort, especially with continued improvements in survival rates in patients with heart failure...
Fulminant acute cellular rejection with negative findings on endomyocardial biopsyRajeshkumar Bhalodolia
Department of Medicine, Saint Louis University School of Medicine, St. Louis, Missouri 63110, USA
J Heart Lung Transplant 25:989-92. 2006....
Variability in the clinical status of patients with advanced heart failurePaul J Hauptman
Department of Medicine, Saint Louis University School of Medicine, Missouri, USA
J Card Fail 10:397-402. 2004....
The impact of kidney transplantation on heart failure risk varies with candidate body mass indexKrista L Lentine
Center for Outcomes Research, Saint Louis University School of Medicine, St Louis, MO 63104, USA
Am Heart J 158:972-82. 2009..The relationship of body mass index (BMI) with heart failure (HF) risk before and after kidney transplant is not well described...
Malignant fibrous histiocytoma of the lung presenting as bronchial obstruction in a heart transplant recipientTariq Alhadab
Division of Pulmonary Medicine, Saint Louis University Health Sciences Center, St. Louis, Missouri, USA
J Heart Lung Transplant 21:1140-3. 2002..Despite attempts at palliative endoscopic argon coagulation, the patient expired soon after presentation...
Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathyAmit A Doshi
Saint Louis University Hospital, Saint Louis University School of Medicine, St. Louis, Missouri 63110, USA
Am J Cardiol 93:90-2. 2004..8 +/- 2.2 years from time of transplant. Periprocedural success was high, and there was a trend toward better outcomes in the group that underwent stent deployment compared with conventional balloon angioplasty...
Panel-reactive antibody screening practices prior to heart transplantationAdam S Betkowski
Division of Cardiology, Department of Medicine, St Louis University Health Sciences Center, St Louis, Missouri 63110, USA
J Heart Lung Transplant 21:644-50. 2002..Important questions about the impact of sensitization on outcomes following heart transplantation may not be resolved until the measurement and management of sensitization becomes more uniform...
beta-Adrenergic receptor blockers and heart failure risk after myocardial infarction: a critical reviewRobert H Neumayr
Division of Cardiology, FDT 15, Saint Louis University Hospital, 3635 Vista Avenue, Saint Louis, MO 63110, USA
Curr Heart Fail Rep 6:220-8. 2009..Areas of uncertainty, such as the selection of dose and duration of therapy, current guidelines, and patterns of underuse of therapy with this important class of drugs are outlined and highlighted...
Consensus statement: Palliative and supportive care in advanced heart failureSarah J Goodlin
Institute for Health Care Delivery and Research, Intermountain Health Care, Salt Lake City, Utah 84111, USA
J Card Fail 10:200-9. 2004....
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failureMilton Packer
University of Texas Southwestern Medical Center, Dallas, Texas 75390 8822, USA
J Am Coll Cardiol 47:2245-52. 2006..This study sought to assess the potential utility of impedance cardiography (ICG) in predicting clinical deterioration in ambulatory patients with heart failure (HF)...
Understanding individual and small area variation in the underuse of coronary angiography following acute myocardial infarctionPushkal P Garg
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115-5899, USA
Med Care 40:614-26. 2002..The causes of regional variation in underuse do not appear to be related to regional differences in patient or hospital characteristics, and therefore, require further study...
Hospice care for heart failure patientsSarah J Goodlin
Palliative Care-Heart Failure Education and Research Trials, Institute for Health Care Delivery Research, Salt Lake City, UT 84111, USA
J Pain Symptom Manage 29:525-8. 2005
Anything does not go: defining and refining interventions designed to improve quality in cardiovascular diseasesPaul J Hauptman
Am J Med 117:433-5. 2004
Limitations of listing criteria for heart transplantation in the United States: call for a critical reviewPaul J Hauptman
J Heart Lung Transplant 23:1123. 2004
Left ventricular assist devicePaul J Hauptman
N Engl J Med 346:1023-5; author reply 1023-5. 2002
Research Grants
- Decision Making in End-Stage Heart FailurePaul Hauptman; Fiscal Year: 2006..These studies will form the conceptual framework for an intervention study designed to address, at physician and patient levels, the process of selection of care options for older heart failure patients near the end of life. ..
